Matthias Vogt

Matthias Vogt currently serves as the Chief Executive Officer a.i. and Chief Financial Officer at Biosynth, a global life sciences reagents and manufacturing services group. Prior to this role, Matthias Vogt was the Chief Financial Officer at SHL Group, where substantial value creation and growth were driven, culminating in a successful exit following EQT's investment. Matthias Vogt's earlier experience includes serving as Chief Financial Officer at Stallergenes Greer, Managing Director at Axalta, and Chief Financial Officer at Merz Group, where a finance function was built to be IPO-ready. Additionally, Matthias Vogt held various CFO positions at Novartis across different regions and functions. Educational qualifications include degrees from prestigious institutions such as WHU – Otto Beisheim School of Management, Harvard Business School, Justus Liebig University Giessen, and the University of Mannheim.